With election year in the rearview mirror, 2021 could bring upside for biotechnology stocks and exchange traded funds if historical trends hold true to form. That would be a boon for the ALPS Medical Breakthroughs ETF (SBIO). There are some encouraging fundamental catalysts at play for SBIO as next...